This balanced reduction in DNMT3A activity could help preserve the expression of genes essential for maintaining the structural and functional integrity of the cochlea, protecting against the cellular stress and damage that lead to hearing loss. The gene discussed is DNMT3A; the disease is hearing loss disorder.